Heparin
15
2
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
40%
6 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (15)
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
Interchangeability of Arterial Coagulation and Venous Coagulation, in the Context of Cardiac Surgeries Under Cardiopulmonary Bypass, Using the DMDiv Hemochron Signature Elite
The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery
Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection
Citrate Dialysate in Online Hemodialfiltration
Continuous Heparin Infusion to Prevent Catheter-related Thrombosis
EMR Tool Impact on HIT Documentation and Management
Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer
Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial
Study With Heparin Sodium in Intravenous Administration
Study With Heparin Sodium in Subcutaneous Administration
The Effect of Citrate Dialysate on Clot Formation and Anemia in Hemodialysis Patients
Adjusted Calculation of Heparin and Protamin Dosing and Correlation With Postoperative Bleeding and Transfusions
The Effect of Heparinization Due to LBW
The Effect of Heparin on Inhalation Injury